These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31727237)

  • 1. Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells.
    Di Virgilio F; Jiang LH; Roger S; Falzoni S; Sarti AC; Vultaggio-Poma V; Chiozzi P; Adinolfi E
    Methods Enzymol; 2019; 629():115-150. PubMed ID: 31727237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of P2X7 receptor on tumorigenesis and its pharmacological properties.
    Zhang WJ; Hu CG; Zhu ZM; Luo HL
    Biomed Pharmacother; 2020 May; 125():109844. PubMed ID: 32004973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based identification and characterisation of structurally novel human P2X7 receptor antagonists.
    Caseley EA; Muench SP; Fishwick CW; Jiang LH
    Biochem Pharmacol; 2016 Sep; 116():130-9. PubMed ID: 27481062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel P2X7R antagonists by using structure-based virtual screening and cell-based assays.
    Zhao Y; Chen X; Lyu S; Ding Z; Wu Y; Gao Y; Du J
    Chem Biol Drug Des; 2021 Jul; 98(1):192-205. PubMed ID: 33993620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2X7 receptors: channels, pores and more.
    Volonté C; Apolloni S; Skaper SD; Burnstock G
    CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):705-21. PubMed ID: 22963440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and Functional Basis for Understanding the Biological Significance of P2X7 Receptor.
    Martínez-Cuesta MÁ; Blanch-Ruiz MA; Ortega-Luna R; Sánchez-López A; Álvarez Á
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglia proliferation is controlled by P2X7 receptors in a Pannexin-1-independent manner during early embryonic spinal cord invasion.
    Rigato C; Swinnen N; Buckinx R; Couillin I; Mangin JM; Rigo JM; Legendre P; Le Corronc H
    J Neurosci; 2012 Aug; 32(34):11559-73. PubMed ID: 22915101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A central role for P2X7 receptors in human microglia.
    Janks L; Sharma CVR; Egan TM
    J Neuroinflammation; 2018 Nov; 15(1):325. PubMed ID: 30463629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2X7 receptor inhibition by 2-amino-3-aryl-1,4-naphthoquinones.
    de Luna Martins D; Borges AA; E Silva NADA; Faria JV; Hoelz LVB; de Souza HVCM; Bello ML; Boechat N; Ferreira VF; Faria RX
    Bioorg Chem; 2020 Nov; 104():104278. PubMed ID: 33010623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120.
    Allsopp RC; Dayl S; Schmid R; Evans RJ
    Sci Rep; 2017 Apr; 7(1):725. PubMed ID: 28389651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment.
    Scarpellino G; Genova T; Munaron L
    Recent Pat Anticancer Drug Discov; 2019; 14(1):32-38. PubMed ID: 30652649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor.
    Hempel C; Nörenberg W; Sobottka H; Urban N; Nicke A; Fischer W; Schaefer M
    Neuropharmacology; 2013 Dec; 75():365-79. PubMed ID: 23954492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors.
    Jelassi B; Anchelin M; Chamouton J; Cayuela ML; Clarysse L; Li J; Goré J; Jiang LH; Roger S
    Carcinogenesis; 2013 Jul; 34(7):1487-96. PubMed ID: 23524196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of bilirubin as novel P2X7R antagonist with anti-tumor activity.
    Zhao Y; Chen X; He C; Gao G; Chen Z; Du J
    Bioorg Med Chem Lett; 2021 Nov; 51():128361. PubMed ID: 34543755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes.
    Narcisse L; Scemes E; Zhao Y; Lee SC; Brosnan CF
    Glia; 2005 Jan; 49(2):245-58. PubMed ID: 15472991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purinergic P2X7 receptor as a potential therapeutic target in depression.
    Qi W; Jin X; Guan W
    Biochem Pharmacol; 2024 Jan; 219():115959. PubMed ID: 38052270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine Macrophages.
    Pacheco PAF; Galvão RMS; Faria AFM; Von Ranke NL; Rangel MS; Ribeiro TM; Bello ML; Rodrigues CR; Ferreira VF; da Rocha DR; Faria RX
    Bioorg Med Chem; 2019 Apr; 27(8):1449-1455. PubMed ID: 30528164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy.
    Khalafalla MG; Woods LT; Camden JM; Khan AA; Limesand KH; Petris MJ; Erb L; Weisman GA
    J Biol Chem; 2017 Oct; 292(40):16626-16637. PubMed ID: 28798231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2X7 receptor antagonism inhibits tumour growth in human high-grade gliomas.
    Kan LK; Seneviratne S; Drummond KJ; Williams DA; O'Brien TJ; Monif M
    Purinergic Signal; 2020 Sep; 16(3):327-336. PubMed ID: 32583309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer.
    Li Q; Zhu X; Song W; Peng X; Zhao R
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):2731-2741. PubMed ID: 32892231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.